A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

ClinicalTrials.gov ID: NCT06457503

Public ClinicalTrials.gov record NCT06457503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 2:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Single-Arm Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants

Study identification

NCT ID: NCT06457503
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: Coherus Oncology, Inc.; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Nasopharyngeal Cancer Recurrent

Interventions

Carboplatin Drug
Cisplatin Drug
Gemcitabine Drug
Toripalimab Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2024
Primary completion: Nov 30, 2027
Completion: Nov 30, 2027
Last update posted: Apr 5, 2026

2024 – 2027

United States locations

U.S. sites: 12
U.S. states: 9
U.S. cities: 12

Facility	City	State	ZIP	Site status
University of Arkansas for Medical Sciences	Little Rock	Arkansas	72205	Recruiting
University of California, Irvine	Irvine	California	92697	Recruiting
University of California, San Francisco	San Francisco	California	94115	Recruiting
Emory Winship Cancer Institute	Atlanta	Georgia	30322	Recruiting
Boston Medical Center	Boston	Massachusetts	02118	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Henry Ford Cancer Center	Detroit	Michigan	48202	Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health	New York	New York	10016	Withdrawn
University of Cincinnati Medical Center	Cincinnati	Ohio	45219	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
Penn State Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	Recruiting
Froedtert Hospital and the Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06457503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 5, 2026 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06457503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →